Develops photodynamic therapy for cutaneous T-cell lymphoma.
Dec 2024Revenue $119K/yrExpenses $9.56M/yr
No trend
Figures by year
When will Soligenix be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $119K and expenses $9.56M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $119K | $9.56M | −$9.44M |
| Dec 2023 | $839K | $8.54M | −$7.70M |
| Dec 2022 | $949K | $15.2M | −$14.2M |
| Dec 2021 | $824K | $13.9M | −$13.1M |
| Dec 2020 | $2.36M | $20.9M | −$18.6M |
| Dec 2019 | $4.63M | $15.2M | −$10.5M |
| Dec 2018 | $5.24M | $14.3M | −$9.06M |
| Dec 2017 | $5.43M | $13.0M | −$7.59M |
| Dec 2016 | $10.4M | $16.2M | −$5.71M |
| Dec 2015 | $8.77M | $15.9M | −$7.11M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.